Thanks so much Crem.. if I could indulge you/another expert with one more follow up question. I believe the patent for Trof in the US/Europe expires in Jan 2032. I assume after that, Trof would be competed with and the price/royalties would reduce significantly? Accordingly the large cashflows are highly finite to the patent/exclusivity period hence the 10x multiple is applied. Is such analysis incorrect, or can you elaborate on why the 25x is more appropriate given the finite earnings window ahead? Or have I got this all wrong?!
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.26%
!
$15.35

NEU chart, page-311
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$15.35 |
Change
-0.040(0.26%) |
Mkt cap ! $1.892B |
Open | High | Low | Value | Volume |
$15.45 | $15.45 | $15.03 | $3.754M | 246.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 1022 | $15.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.36 | 306 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 126 | 15.360 |
5 | 703 | 15.350 |
8 | 1392 | 15.340 |
13 | 1473 | 15.330 |
11 | 1709 | 15.320 |
Price($) | Vol. | No. |
---|---|---|
15.380 | 349 | 5 |
15.390 | 425 | 3 |
15.400 | 399 | 3 |
15.410 | 1115 | 5 |
15.420 | 1263 | 6 |
Last trade - 12.43pm 21/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |